Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight
The interleukin-23 inhibitors market is witnessing robust growth driven by the rising prevalence of autoimmune diseases like psoriasis and inflammatory bowel disease. Advancements in biologics and increased adoption of targeted therapies are further accelerating demand. Favorable reimbursement policies and growing awareness among healthcare providers are also contributing to market expansion. The IL-23 inhibitors market is […]